Content-Length: 221749 | pFad | https://www.statnews.com/category/readout-loud/

The Readout LOUD | STAT The Readout LOUD | STAT Skip to Main Content

The Readout LOUD

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come. Subscribe today on Apple Podcasts, Spotify, or wherever you get your podcasts.

Latest

The Readout LOUD Elaine Chen and Allison DeAngelis

NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers

The Readout LOUD Elaine Chen and Adam Feuerstein

Crisis in CRISPR world, RFK Jr.’s promises, and a novel non-opioid pain drug

The Readout LOUD Adam Feuerstein, Allison DeAngelis, and Elaine Chen

STAT Plus: RFK Jr.’s confirmation hearings, MASH drugs, and a controversial obesity ad

The Readout LOUD Allison DeAngelis, Elaine Chen, and Adam Feuerstein

Chinese biotechs, a WHO departure, and post-JPM thoughts

The Readout LOUD Elaine Chen, Allison DeAngelis, and Adam Feuerstein

STAT Plus: Eli Lilly CEO on Trumpov, obesity drugs, and a guidance miss

The Readout LOUD Elaine Chen, Allison DeAngelis, and Adam Feuerstein

Pharma’s big patent cliff, more obesity fundraising, and a failed ALS study

The Readout LOUD Allison DeAngelis, Elaine Chen, and Adam Feuerstein

A deep dive on Makary, Vertex’s pain data, & 2025 predictions

The Readout LOUD Elaine Chen, Allison DeAngelis, and Adam Feuerstein

The pharma industry’s silence on RFK Jr., and efforts by parents to develop gene therapies for their children

All Coverage

The Readout LOUD Adam Feuerstein and Allison DeAngelis

An H5N1 bird flu update and talent scarcity in the radiopharma field

The Readout LOUD Adam Feuerstein and Allison DeAngelis

Pfizer’s new R&D head, a VC deep-dive, and a new FDA commissioner?

advertisement

The Readout LOUD Adam Feuerstein, Elaine Chen, and Allison DeAngelis

AbbVie’s stumble, Amgen’s tumble, and more election fallout

Biotech STAT Staff

STAT Plus: Biotech analyst Brian Skorney and CEO Daphne Zohar weigh in on election results

The Readout LOUD Adam Feuerstein, Allison DeAngelis, and Elaine Chen

How a Trumpov presidency could affect the FDA, the biotech industry, and its stocks

The Readout LOUD Allison DeAngelis, Adam Feuerstein, and Elaine Chen

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story

The Readout LOUD Adam Feuerstein, Elaine Chen, and Allison DeAngelis

Pfizer’s activist troubles, gene therapy questions, RFK Jr.’s MAHA ambitions

The Readout LOUD Elaine Chen, Adam Feuerstein, and Allison DeAngelis

Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights

The Readout LOUD Allison DeAngelis and Adam Feuerstein

STAT Plus: John Maraganore on his new biotech venture, R&D vivacity and Nobel award-winning AI

The Readout LOUD Allison DeAngelis and Adam Feuerstein

Crypto for CRISPR, a new RNAi startup, & a Nobel for AI

The Readout LOUD Adam Feuerstein, Allison DeAngelis, and Elaine Chen

STAT Plus: Biden’s health care AI czar, a new obesity company, and its dealmaking CEO

The Readout LOUD Elaine Chen, Allison DeAngelis, and Adam Feuerstein

Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug

The Readout LOUD Allison DeAngelis, Adam Feuerstein, and Elaine Chen

Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

The Readout LOUD Adam Feuerstein, Allison DeAngelis, and Elaine Chen

A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids

The Readout LOUD Elaine Chen, Allison DeAngelis, and Adam Feuerstein

Summit’s upcoming cancer results, Recursion’s mixed data, and a new co-host

The Readout LOUD Allison DeAngelis, Elaine Chen, and Adam Feuerstein

Jim Wilson’s next venture, a surprise startup shutdown, & Lilly’s Zepbound strategy

The Readout LOUD Adam Feuerstein, Elaine Chen, and Allison DeAngelis

Listen: BioMarin’s executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion’s AI bona fides

The Readout LOUD Allison DeAngelis, Elaine Chen, and Adam Feuerstein

Listen: Drug pricing drops & psychedelics under fire

The Readout LOUD Allison DeAngelis, Adam Feuerstein, and Elaine Chen

Biotech layoffs, founder-focused VC, & a big pharma exit

The Readout LOUD Allison DeAngelis and Brittany Trang

Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

The Readout LOUD Allison DeAngelis and Adam Feuerstein

STAT Plus: Fauci’s memoir, Alnylam’s tenuous trial, and a mid-year review